IL216896A0 - A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition - Google Patents

A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition

Info

Publication number
IL216896A0
IL216896A0 IL216896A IL21689611A IL216896A0 IL 216896 A0 IL216896 A0 IL 216896A0 IL 216896 A IL216896 A IL 216896A IL 21689611 A IL21689611 A IL 21689611A IL 216896 A0 IL216896 A0 IL 216896A0
Authority
IL
Israel
Prior art keywords
alleviation
relieving
disorder
symptoms
improving
Prior art date
Application number
IL216896A
Other versions
IL216896A (en
Original Assignee
Alcobra Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2010/000506 external-priority patent/WO2010150261A1/en
Application filed by Alcobra Ltd filed Critical Alcobra Ltd
Priority to IL216896A priority Critical patent/IL216896A/en
Publication of IL216896A0 publication Critical patent/IL216896A0/en
Publication of IL216896A publication Critical patent/IL216896A/en

Links

IL216896A 2009-06-25 2011-12-11 Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects IL216896A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL216896A IL216896A (en) 2009-06-25 2011-12-11 Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22037609P 2009-06-25 2009-06-25
US30564110P 2010-02-18 2010-02-18
PCT/IL2010/000506 WO2010150261A1 (en) 2009-06-25 2010-06-24 A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
IL216896A IL216896A (en) 2009-06-25 2011-12-11 Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects

Publications (2)

Publication Number Publication Date
IL216896A0 true IL216896A0 (en) 2012-02-29
IL216896A IL216896A (en) 2016-09-29

Family

ID=45855179

Family Applications (1)

Application Number Title Priority Date Filing Date
IL216896A IL216896A (en) 2009-06-25 2011-12-11 Metadoxine and compositions comprising the same for use in the treatment of adhd/add in non-alcoholic subjects

Country Status (1)

Country Link
IL (1) IL216896A (en)

Also Published As

Publication number Publication date
IL216896A (en) 2016-09-29

Similar Documents

Publication Publication Date Title
HK1171370A1 (en) A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
IL259475A (en) Combination therapy for the treatment of diabetes
EP2485797A4 (en) Systems, devices and methods for the treatment of neurological disorders and conditions
HK1217293A1 (en) Methods for the prevention or treatment of heart failure
EP2512578A4 (en) Devices and methods for treating sinus disease
EP2432476A4 (en) Methods for treating or preventing ophthalmological diseases
EP2651496A4 (en) Devices, systems and methods for the treatment of medical disorders
IL210856A0 (en) Combination therapy for the treatment of diabetes and related conditions
EP2349140A4 (en) Devices, systems and methods for the treatment of sleep apnea
AP2011005672A0 (en) Pyrazolopyrimidines and their use for the treatment of CNS disorders.
EP2278972A4 (en) Treatment for neurological and mental disorders
EP2512507A4 (en) Treatment of nasal and sinus disorders
SG2014011266A (en) Methods and systems for diagnosis and treatment of a defined condition, and methods for operating such systems
EP2328914A4 (en) Prevention, treatment and diagnosis of p.gingivalis infection
ZA201201222B (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-derivatives,methods for the production thereof and use thereof for treating diseases
EP2405928A4 (en) Treatment and diagnostic methods for hypersensitive disorders
EP2490721A4 (en) Compositions, methods for treatment, and diagnoses of autoimmunity-related disorders and methods for making such compositions
HK1173181A1 (en) Medicament and agent for treating and diagnosing immune disorders and their use
WO2011041325A3 (en) Methods and compositions for the treatment of viral disorders
IL215990A0 (en) Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disorders
AP2011005843A0 (en) Use of deferiprone for treatment and prevention ofiron-related eye disorders.
WO2010115078A3 (en) Method of treating cognitive impairment
EP2654434A4 (en) Methods for treating dental diseases, disorders and injuries
IL216896A0 (en) A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
EP2225366A4 (en) Use of enterovirus for diagnostics, treatment and prevention of disease

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees